EuroAPI Header EuroAPI Header

X
[{"orgOrder":0,"company":"Quest Products","sponsor":"Quest Products, LLC","pharmaFlowCategory":"D","amount":"Undisclosed","upfrontCash":"Undisclosed","newsHeadline":"Quest Products, LLC. Acquires Summit Pharmaceuticals \/ Alliance Labs, Including Enemeez\u00ae and DocuSol\u00ae Brands","therapeuticArea":"Gastroenterology","highestDevelopmentStatus":"Approved","country":"U.S.A","productType":"Small molecule","productStatus":"Approved","date":"June 2020","url1":"","url2":"","graph1":"Gastroenterology","graph2":"Approved"}]

Find Clinical Drug Pipeline Developments & Deals for Docusate Potassium

Menu
Loading...
Filters Filter
×
FILTER:
filter Company
    filter Sponsor
      filter Country
        filter Therapeutic Area
          filter Study Phase

            Active Filter(s):

            Companies By Therapeutic Area

            Development Status

            Details:

            Quest will add the Enemeez and DocuSol brands of bowel care products, to its' portfolio of self-care products.

            Lead Product(s): Docusate Potassium

            Therapeutic Area: Gastroenterology Product Name: Enemeez

            Highest Development Status: Approved Product Type: Small molecule

            Partner/Sponsor/Collaborator: Quest Products, LLC

            Deal Size: Undisclosed Upfront Cash: Undisclosed

            Deal Type: Acquisition June 24, 2020

            ASK
            US
            PHARMACOMPASS
            Upload
            your Pipeline Activity
            Post Enquiry
            POST ENQUIRY